Clinical Trials Browser

Terminated × Interventional × relugolix × Clear all

NCT05679388 2024-09-19

A Study of Extending Relugolix Dosing Intervals Through Addition of Itraconazole or Ritonavir in Prostate Cancer Patients

Phase 1 Terminated

Prostatic Neoplasms